Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction

Cancer Cell. 2003 May;3(5):431-7. doi: 10.1016/s1535-6108(03)00113-2.

Abstract

Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibody Specificity
  • Antigen Presentation
  • Cell Survival
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Models, Biological
  • Neoplasms / therapy*
  • Protein Structure, Tertiary
  • T-Lymphocytes / immunology*